The Pediatric Praziquantel Consortium says it has achieved a milestone by administering arpraziquantel to the first preschool-aged child for the treatment of schistosomiasis, otherwise known as snail fever.
It was disclosed that Uganda became the first country to introduce arpraziquantel to children under five, marking a significant step toward expanding treatment access.
According to a statement, this marks an advancement in the fight…
Read the full article here
